Mednax Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,154
2,439
2,780
3,183
3,458
3,647
Cost of Goods Sold (COGS) incl. D&A
1,482
1,678
1,916
2,239
2,561
2,769
Gross Income
672
761
864
944
897
878
SG&A Expense
218
248
288
357
417
432
EBIT
454
513
576
587
480
446
Unusual Expense
2
-
18
15
-
-
Interest Expense
5
9
23
63
75
89
Pretax Income
448
509
540
514
410
369
Income Tax
168
191
204
189
90
100
Consolidated Net Income
281
317
336
325
320
269
Net Income
281
317
336
325
320
269
Net Income After Extraordinaries
281
317
336
325
320
269
Net Income Available to Common
281
317
336
325
320
269
EPS (Basic)
2.78
3.18
3.58
3.49
3.45
2.93
Basic Shares Outstanding
99
99
93
92
92
91
EPS (Diluted)
2.78
3.18
3.58
3.49
3.45
2.93
Diluted Shares Outstanding
101
100
94
93
93
92
EBITDA
494
559
640
676
583
557
Non-Operating Interest Income
2
3
2
2
4
5
Minority Interest Expense
-
-
1
-
-
-
Equity in Affiliates (Pretax)
-
2
3
3
1
7

About Mednax

View Profile
Address
1301 Concord Terrace
Sunrise Florida 33323
United States
Employees -
Website http://www.mednax.com
Updated 07/08/2019
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J.